This study is a double blind clinical trial on 80 patients with hypertension and dyslipidemia.
The study process can be summarized in three steps:
1) the preparation of flaxseed powder and placebo in sachet form by Kamvar company, Isfahan, Iran. Participants will consume either 36 gram flaxseed sachet or 12 gram placebo sachet per day during study.
2) At first, form referring patients to affiliated clinics with Isfahan university of medical sciences, 80 patients with dyslipidemia and high blood pressure will be selected based on inclusion criteria by a cardiologist and after that will be recruited to this study . After taking informed written consent, patients will randomly be assigned to either intervention group (36 gram flaxseed sachet per day) or placebo group (12 gram sachet placebo per day ) for 8 week.
Biochemical assessment including lipid profiles (TG, LDL-C, HDL-C, Total-C), C-reactive protein, fasting blood sugar, anthropometric indices (weight, height, waist circumference, hip circumference, waist to hip ratio), systolic and diastolic blood pressure and physical activity will be measured at the beginning and end of study. 3-day dietary record will be obtained from all participants at week 0, 4 and 8. 3) Data will be analyzed by using SPSS software.